Warning: The NCBI web site requires JavaScript to function. more...
Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau JY.
Arthritis Res Ther. 2008;10(1):R6. Epub 2008 Jan 16.
Related citations
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.
Agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a new compound with potent gastroprotective and ulcer healing properties.
Brzozowski T, Konturek PC, Pajdo R, Kwiecień SN, Konturek S, Targosz A, Burnat G, Cieszkowski J, Pawlik WW, Hahn EG.
Inflammopharmacology. 2005;13(1-3):317-30.
Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db/db mice.
Mohapatra J, Sharma M, Singh S, Chatterjee A, Swain P, Balaraman R, Patel PR, Jain MR.
Pharmacology. 2009;84(4):203-10. Epub 2009 Sep 5.
Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies.
Lewthwaite J, Blake S, Hardingham T, Foulkes R, Stephens S, Chaplin L, Emtage S, Catterall C, Short S, Nesbitt A, et al.
Ann Rheum Dis. 1995 May;54(5):366-74.
Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM.
Biochem Biophys Res Commun. 2005 Oct 28;336(3):747-53.
IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
Rath-Wolfson L, Bar-Yehuda S, Madi L, Ochaion A, Cohen S, Zabutti A, Fishman P.
Clin Exp Rheumatol. 2006 Jul-Aug;24(4):400-6.
Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
Yamamoto N, Sakai F, Yamazaki H, Kawai Y, Nakahara K, Okuhara M.
J Rheumatol. 1996 Oct;23(10):1778-83.
Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
Cuzzocrea S, Mazzon E, Dugo L, Patel NS, Serraino I, Di Paola R, Genovese T, Britti D, De Maio M, Caputi AP, Thiemermann C.
Arthritis Rheum. 2003 Dec;48(12):3544-56.
Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis.
Larsen PJ, Jensen PB, Sørensen RV, Larsen LK, Vrang N, Wulff EM, Wassermann K.
Diabetes. 2003 Sep;52(9):2249-59.
The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta.
Toba H, Miki S, Shimizu T, Yoshimura A, Inoue R, Sawai N, Tsukamoto R, Murakami M, Morita Y, Nakayama Y, Kobara M, Nakata T.
Eur J Pharmacol. 2006 Nov 7;549(1-3):124-32. Epub 2006 Aug 30.
PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis.
Hassumi MY, Silva-Filho VJ, Campos-Júnior JC, Vieira SM, Cunha FQ, Alves PM, Alves JB, Kawai T, Gonçalves RB, Napimoga MH.
Int Immunopharmacol. 2009 Sep;9(10):1150-8. Epub 2009 Jun 7.
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
Herrak P, Görtz B, Hayer S, Redlich K, Reiter E, Gasser J, Bergmeister H, Kollias G, Smolen JS, Schett G.
Arthritis Rheum. 2004 Jul;50(7):2327-37.
[Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases - the pro and con of agonists].
Jouzeau JY, Moulin D, Koufany M, Sebillaud S, Bianchi A, Netter P.
J Soc Biol. 2008;202(4):289-312. Epub 2008 Dec 19. Review. French.
Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
Magari K, Nishigaki F, Sasakawa T, Ogawa T, Miyata S, Ohkubo Y, Mutoh S, Goto T.
Inflamm Res. 2003 Dec;52(12):524-9. Epub 2003 Nov 13.
Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis.
Campagnuolo G, Bolon B, Feige U.
Arthritis Rheum. 2002 Jul;46(7):1926-36.
Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
Arthritis Rheum. 2005 Mar;52(3):759-69.
Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.
Kim H, Haluzik M, Gavrilova O, Yakar S, Portas J, Sun H, Pajvani UB, Scherer PE, LeRoith D.
Diabetologia. 2004 Dec;47(12):2215-25. Epub 2004 Dec 15.
Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells.
Li X, Kimura H, Hirota K, Sugimoto H, Kimura N, Takahashi N, Fujii H, Yoshida H.
Nephrol Dial Transplant. 2007 Apr;22(4):1041-51. Epub 2007 Jan 25.
Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis.
Mould AW, Tonks ID, Cahill MM, Pettit AR, Thomas R, Hayward NK, Kay GF.
Arthritis Rheum. 2003 Sep;48(9):2660-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on